EPI Act Eliminate Price Increases Act of 2016
Do you support it?
Want to know if it passes?
We'll email you when HR 6284 moves — a committee vote, a floor vote, or a signature. Nothing else.
Free forever · unsubscribe in one click.
Your answer was recorded either way.
Which district are you in?
Your ZIP is all we need to match you to your own representatives — so we can tell you how they voted on HR 6284.
You're tracking HR 6284
We'll email you the moment it moves.
HR 6284 — EPI Act Eliminate Price Increases Act of 2016
Last action — Referred to the House Committee on Energy and Commerce.
No card. One bill, free forever — alerts when it moves.
-
✓Introduced
-
✓In Committee
-
Died in session
This bill died with 114th Congress. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.
Summary
EPI Act Eliminate Price Increases Act of 2016 This bill amends the Federal Food, Drug, and Cosmetic Act to prohibit the manufacturer of a brand name drug from authorizing or commencing the manufacturing, marketing, selling, or distributing of a generic version of the drug from the time the manufacturer is notified by a generic manufacturer that a generic drug application has been submitted until the expiration or forfeiture of the 180-day exclusivity period granted to the generic manufacturer.
Bill Text
We don't have the full text on file for this bill yet.
Read HR 6284 on the official United States source →Action History
-
Referred to the House Committee on Energy and Commerce.
-
Introduced in House
Sponsors
- Adam Smith · Primary
Sponsorship breakdown
Export CSV (upgrade) →1 sponsors · 0 co-sponsors · 546 not signed on
Sponsors (1)
Co-sponsors (0)
None.
Not signed on (546)
546 members have not signed on to this bill.
Show all 546 →"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.
Subjects
Frequently asked questions
- What does HR 6284 do?
- EPI Act Eliminate Price Increases Act of 2016 This bill amends the Federal Food, Drug, and Cosmetic Act to prohibit the manufacturer of a brand name drug from authorizing or commencing the manufacturing, marketing, selling, or distributing of a generic version of the drug from the time the manufacturer is notified by a generic manufacturer that a generic drug application has been submitted until the expiration or forfeiture of the 180-day exclusivity period granted to the generic manufacturer.
- Who sponsors HR 6284?
- HR 6284 is sponsored by Adam Smith (D).
- What is the current status of HR 6284?
- This bill died with 114th Congress. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
- Where can I track HR 6284?
- Track HR 6284 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on HR 6284
Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.
Stay ahead of HR 6284
Last checked for changes about 11 hours ago · updated continuously
One Click Politics tracks every bill in Congress and all 50 states.
Track this bill →